Omni Legend vs EchoNext
AI Verdict
Choose Omni Legend if…
Choose Omni Legend if your institution requires a state-of-the-art, on-premise PET/CT system for comprehensive diagnostic imaging across oncology, cardiology, and neurology. Its ultra-high sensitivity, AI-enhanced workflow, and superior small lesion detectability make it ideal for advanced research and precise clinical diagnoses where minimizing scan time and radiation dose are critical.
View Omni Legend →Choose EchoNext if…
Choose EchoNext if your practice or hospital seeks an accessible, non-invasive AI tool to augment standard ECG analysis for early detection of hidden structural heart disease. Its ability to screen for conditions like heart failure, valve disease, and pulmonary hypertension using existing ECG infrastructure makes it suitable for broad deployment in primary care, cardiology, and hospital medicine settings to improve patient outcomes through early intervention.
View EchoNext →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | Omni Legend | EchoNext |
|---|---|---|
| Pricing | Contact vendor | Starts at $600/month |
| Deployment | On-premise (physical medical device) | Available through the OpenEvidence clinical decision support platform. |
| BAA Available | Unknown | Yes AI-estimated |
| FDA Status | Yes AI-estimated | Yes AI-estimated |
| HIPAA | Unknown | Yes AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
Omni LegendOmni Legend emphasizes AI-enhanced workflow solutions, including 'Auto Positioning' for patient setup and simplified protocol selection on gantry touchscreens, aiming to reduce technologist burden and improve patient comfort with features like ambient lighting. EchoNext is integrated into the OpenEvidence platform, which is used by many clinicians, suggesting a degree of accessibility, but its direct usability features for the end-user are less detailed.
Clinical Value
EchoNextEchoNext has demonstrated high accuracy in detecting structural heart disease from standard ECGs, outperforming cardiologists in studies and leading to earlier diagnoses, including a case resulting in a heart transplant. Omni Legend offers ultra-high sensitivity and improved small lesion detectability in PET/CT scans, which is valuable for various applications, but EchoNext's ability to identify previously undiagnosed, critical conditions from a widely available, inexpensive test presents a broader and more immediate clinical impact.
Pricing & Value
EchoNextEchoNext provides transparent tiered pricing starting at $600/month, with discounts and add-ons clearly outlined. Omni Legend's pricing is not publicly available and requires direct vendor consultation, making it difficult to assess its value proposition without engaging sales.
Enterprise Readiness
TieBoth tools demonstrate enterprise readiness. Omni Legend, as a GE HealthCare product, is expected to adhere to HIPAA and likely has BAA in place, and its deployment as a physical medical device within established healthcare systems indicates robust integration capabilities. EchoNext is FDA-cleared, HIPAA compliant, has a BAA, and is deployed through the OpenEvidence clinical decision support platform, which is used by a large number of US clinicians, suggesting broad accessibility and integration into existing workflows.
Innovation
Omni LegendOmni Legend introduces an all-digital PET/CT platform with a new digital BGO detector and Precision DL deep learning image processing, offering ultra-high sensitivity and improved small lesion detectability. While EchoNext's application of AI to ECGs for structural heart disease detection is innovative, Omni Legend's foundational advancements in imaging hardware and integrated AI for image processing and workflow represent a broader technological leap in medical imaging.
Support & Docs
TieBoth companies are established in the healthcare space. GE HealthCare, as a large medical device manufacturer, is expected to have comprehensive support and documentation for Omni Legend. Pathway Labs, with its FDA-cleared EchoNext and partnerships, is also likely to provide adequate support and documentation, especially given its integration with the OpenEvidence platform. However, specific details on the breadth and depth of support and documentation for either product are not explicitly provided in the given information or readily available through web search.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | Omni Legend | EchoNext |
|---|---|---|
| Name | Omni Legend | EchoNext |
| Company | GE HealthCare | Pathway Labs |
| Description | Omni Legend is GE HealthCare's AI-enhanced, all-digital PET/CT system offering ultra-high sensitivity, faster scans, lower dose, and superior small lesion detectability for oncology, cardiology, and neurology applications. | EchoNext is an FDA-cleared AI tool from Pathway Labs that analyzes standard ECGs to detect hidden structural heart disease, including heart failure, valve disease, and pulmonary hypertension. |
| Primary Categories | Cardiology AI, Neurology AI, Oncology AI | Cardiology AI, Clinical Decision Support & Reference, Lab & Diagnostics |
| Key Features | All-digital Omni platform with new digital BGO (dBGO) detector, Precision DL deep learning image processing for enhanced image quality, AI-enhanced workflow solutions, including Auto Positioning for patient setup, Ultra-high NEMA sensitivity (highest per cm in the market), Faster scan times, enabling ultra-fast whole-body imaging (e.g., 7-8 minutes), Reduced radiation dose for patient safety, Improved small lesion detectability (as small as 0.5mm), Enhanced patient comfort features (LED ambient lighting, soothing bore patterns) | AI-powered ECG analysis, Detection of hidden structural heart disease, Identifies heart failure risk, Screens for valve disease, Detects pulmonary hypertension indicators, Utilizes standard 12-lead ECGs, FDA-cleared technology, Non-invasive diagnostic support |
Videos
Demos, reviews, and walkthroughs featuring Omni Legend and EchoNext.